We are live on ! Find out more
CCM

Callodine Capital Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 8.74%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+8.74%
3 Year Est. Return
+43.6%
5 Year Est. Return
+40.63%
10 Year Est. Return
AUM
$336M
AUM Growth
+$14.4M
Cap. Flow
-$10M
Cap. Flow %
-2.98%
Top 10 Hldgs %
55.65%
Holding
52
New
7
Increased
17
Reduced
14
Closed
9

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$11.7M
2
CMCSA icon
Comcast
CMCSA
+$8.1M
3
GSK icon
GSK
GSK
+$6.99M
4
BXSL icon
Blackstone Secured Lending
BXSL
+$5.45M
5
CG icon
Carlyle Group
CG
+$3.57M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$15.1M
2
VST icon
Vistra
VST
+$9.23M
3
BMY icon
Bristol-Myers Squibb
BMY
+$6.41M
4
VVV icon
Valvoline
VVV
+$5.5M
5
ARES icon
Ares Management
ARES
+$5.41M

Sector Composition

Rank Sector Weight
1 Financials 53.11%
2 Healthcare 15.91%
3 Real Estate 9.15%
4 Consumer Staples 5.81%
5 Consumer Discretionary 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VVV icon
51
Valvoline
VVV
$4.51B
-217,214
Closed -$5.5M
GAP
52
The Gap Inc
GAP
$7.37B
-25,000
Closed -$205K

Similar funds

Callodine Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Callodine Capital Management held 52 positions worth $336M, up 4.5% from $322M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Callodine Capital Management's Q4 2022 filing shows 7 new, 17 increased, 14 reduced and 9 closed positions. Its largest new stake was Comcast: 245,000 shares worth $8.57M. The largest sale was Merck, an estimated $15.1M.

By sector, the portfolio is most concentrated in Financials at 53% of assets, down from 54% a quarter earlier, followed by Healthcare and Real Estate.

  • Callodine Capital Management's largest Q4 2022 buy was Comcast: 245,000 shares worth $8.57M.
  • Callodine Capital Management added most to Crown Castle in Q4 2022, an estimated $11.7M increase.
  • Callodine Capital Management's biggest Q4 2022 reduction was Vistra, cutting an estimated $9.23M.
  • Callodine Capital Management fully exited Merck in Q4 2022, selling an estimated $15.1M.
  • Callodine Capital Management's ten largest holdings make up 56% of its $336M portfolio in Q4 2022.
  • Callodine Capital Management opened 7 new positions and closed 9 in Q4 2022.
  • Callodine Capital Management's portfolio value rose 4.5% quarter-over-quarter to $336M.

Based on Callodine Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.